NDC 76045-235-01 - Diphenhydramine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76045-235
- Requested NDC
- 76045-235-01
- Package NDCs from labels
- 76045-235-01, 76045-235-10
- Manufacturer
- Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC
- Effective date
- 2025-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SODIUM HYDROXIDE - Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC | 2025-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76045-235-01 | Diphenhydramine Hydrochloride | 1 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 1 | 13 | |
| 76045-235-01 | Diphenhydramine Hydrochloride | 1 in 1 BLISTER PACK | INJECTION, SOLUTION | 1 | 13 | |
| 76045-235-10 | Diphenhydramine Hydrochloride | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Diphenhydramine Hydrochloride | ACTIVE INGREDIENT | TC2D6JAD40 | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [BD RX INC.] | 7 | |
| Diphenhydramine | ACTIVE MOIETY | 8GTS82S83M | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [BD RX INC.] | 7 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [BD RX INC.] | 7 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [BD RX INC.] | 7 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION [BD RX INC.] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 059QF0KO0R |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Armas Pharmaceuticals Inc. | c1cd6138-ca31-4bb5-ae47-2d80d4d54f9d | 2023-07-20 | Warnings, Adverse reactions | TC2D6JAD40 |
| REFL HS | ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) | Deseret Biologicals, Inc. | 2fe2d3c1-1829-4a33-be8e-2bad52546f36 | 2023-07-17 | Warnings | QTT17582CB |
| Sleep Aid | SLEEP AID | Better Living Brands LLC | 2b730fa5-47f9-468d-86ed-0d49d9cd8dc4 | 2023-07-06 | Warnings | TC2D6JAD40 |
| Bacteriostatic Water | WATER | Medical Purchasing Solutions, LLC | 69485218-9343-952d-e053-2a91aa0ad4e8 | 2023-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | STERILE WATER | Hikma Pharmaceuticals USA Inc. | b20a28b0-7dfa-42eb-9177-ec256d5a5ef7 | 2023-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | bf7ab250-38b0-ba29-e053-2a95a90a8f32 | 2023-04-27 | Warnings, Adverse reactions | TC2D6JAD40 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 95fbf4c2-c96e-2d41-e053-2995a90a0d54 | 2023-04-26 | Warnings, Adverse reactions | TC2D6JAD40 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 6671c8d0-1f5d-0d77-e053-2a91aa0a7585 | 2023-04-26 | Warnings, Adverse reactions | TC2D6JAD40 |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Acidum Muriaticum | ACIDUM MURIATICUM | Hahnemann Laboratories, INC. | f2aad04c-5151-6cab-e053-2a95a90ad3a7 | 2023-01-19 | QTT17582CB | |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | TOP CARE (Topco Associates LLC) | c62c6319-65eb-37e8-e053-2a95a90a9f90 | 2022-12-28 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | Wal-Mart Stores, Inc. | ba31970a-b952-467c-b3f8-44f7a513de34 | 2022-12-28 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CHAIN DRUG MARKETING ASSOCIATION INC. | c483bbd6-934b-660a-e053-2995a90a51b3 | 2022-12-27 | Warnings | TC2D6JAD40 |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | CVS Pharmacy | ce4378c0-848e-7878-e053-2a95a90af0f3 | 2022-12-27 | Warnings | TC2D6JAD40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.